Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy-Reference-Cited by-同舟云学术

Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy

Published:2015-08 Issue:8 Volume:99 Page:1709-1714
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Quintana Luis F.,Blasco Miquel,Seras Miguel,Pérez Nuria S.,López-Hoyos Marcos,Villarroel Patricia,Rodrigo Emilio,Viñas Odette,Ercilla Guadalupe,Diekmann Fritz,Gómez-Roman José J.,Fernandez-Fresnedo Gema,Oppenheimer Federico,Arias Manuel,Campistol Josep M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference14 articles.

1. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey.;Glassock;Am J Kidney Dis,2010

2. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study.;Dabade;Am J Transplant,2008

3. Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies.;El-Zoghby;Am J Transplant,2009

4. Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN).;Moroni;Nephrol Dial Transplant,2010

5. Recurrence of membranous nephropathy after renal transplantation. Incidence and risk factors in 1614 patients.;Couchoud;Transplantation,1995

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pretransplant Treatment to Avoid Recurrent Membranous Nephropathy in a Kidney Transplant Recipient: A Case Report;Kidney Medicine;2024-06

2. Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study;American Journal of Transplantation;2024-06

3. Recurrence of Idiopathic Membranous Nephropathy in the Kidney Allograft: A Systematic Review;Biomedicines;2024-03-26

4. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024

5. Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy;Terapevticheskii arkhiv;2023-08-17